- English (USA)
- English (UK)
- English (India)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Hvivo PLC (HVO)
Hvivo PLC stock price live, this page displays LON HVO stock exchange data. View the HVO premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Hvivo PLC real time stock price chart below.
What Is the Hvivo PLC Stock Price Today?
The Hvivo PLC stock price today is 5.90.
What Is the Stock Symbol for Hvivo PLC?
The stock symbol for Hvivo PLC is "HVO."
What Stock Exchange Does Hvivo PLC Trade On?
Hvivo PLC is listed and trades on the London stock exchange.
Is Hvivo PLC a Good Stock to Buy?
Determining whether Hvivo PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HVO quote. (ISIN: GB00B9275X97)
What Is the Hvivo PLC Stock Price Today?
The Hvivo PLC stock price today is 5.90.
What Is the Stock Symbol for Hvivo PLC?
The stock symbol for Hvivo PLC is "HVO."
What Stock Exchange Does Hvivo PLC Trade On?
Hvivo PLC is listed and trades on the London stock exchange.
Is Hvivo PLC a Good Stock to Buy?
Determining whether Hvivo PLC—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the HVO quote. (ISIN: GB00B9275X97)
5.90
-0.20(-3.28%)
Closed·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.70
6.20
52 wk Range
4.30
11.00
HVO is not included in our AI-picked strategies. See which stocks are.
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
5.706.20
52 wk Range
4.3011.00
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Book Value / Share
HVO Scorecard
Company’s Health
Assesses a company's financial position by analyzing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Price Target
15.50
Upside
+162.71%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Quickly burning through cash
hVIVO announces annual report and upcoming AGM- Investing.com
hVIVO expands with German units acquisition for €10m- Investing.com
hVIVO signs consultancy deal with Decoy Therapeutics- Investing.com
- hVIVO signs consultancy deal with Decoy Therapeutics
- Investing.com
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Analyst Ratings
5 Buy
2 Hold
0 Sell
Ratings:
7 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 15.50
(+162.71% Upside)
Earnings
Latest Release
Sep 15, 2026
EPS / Forecast
-0.01 / --
Revenue / Forecast
16.27M / --
Compare HVO to Peers and Sector
Metrics to compare | HVO | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipHVOPeersSector | |
|---|---|---|---|---|
P/E Ratio | −7.0x | −1.6x | −0.4x | |
PEG Ratio | 0.04 | −0.08 | 0.00 | |
Price/Book | 1.1x | 2.6x | 2.6x | |
Price / LTM Sales | 0.8x | 2.4x | 3.0x | |
Upside (Analyst Target) | 152.1% | 25.3% | 56.5% | |
Fair Value Upside | Unlock | 4.8% | 8.5% | Unlock |
hVIVO plc operates as a full-service early specialist contract research organisation in the United Kingdom, Europe, and North America. It provides end-to-end early clinical development services to the biopharmaceutical industry, including phase I capabilities and world leading human challenge trial services. The company is involved in the testing of vaccines and antivirals using human challenge clinical trials; and provision of laboratory services, including virology, immunology and biomarker analysis, as well as assay development, sample analysis, and data interpretation. In addition, the company offers services combined with specialisms in infectious diseases, respiratory, and cardiometabolic therapeutical areas. Further, it provides preclinical and early clinical research services; sales and marketing services; data management; storage solutions; and statistics services, as well as drug development consultancy and services. The company also provides clinical research services, including early-phase trials and human pharmacological studies. The company was formerly known as Open Orphan Plc and changed its name to hVIVO plc in October 2022. hVIVO plc is headquartered in London, the United Kingdom.
Ownership
Ownership Overview
Top Holders
People Also Watch
FAQ
What Is the Hvivo (HVO) Stock Price Today?
The Hvivo stock price today is 5.90 GBP.
What Stock Exchange Does Hvivo Trade On?
Hvivo is listed and trades on the London Stock Exchange.
What Is the Stock Symbol for Hvivo?
The stock symbol for Hvivo is "HVO."
What Is the Hvivo Market Cap?
As of today, Hvivo market cap is 40.53M GBP.
What Is Hvivo's Earnings Per Share (TTM)?
The Hvivo EPS (TTM) is -0.01.
When Is the Next Hvivo Earnings Date?
Hvivo will release its next earnings report on Sep 15, 2026.
From a Technical Analysis Perspective, Is HVO a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Hvivo Stock Split?
Hvivo has split 0 times.
How Many Employees Does Hvivo Have?
Hvivo has 376 employees.
What is the current trading status of Hvivo (HVO)?
As of Sep 17, 2026, Hvivo (HVO) is trading at a price of 5.90 GBP, with a previous close of 5.90 GBP. The stock has fluctuated within a day range of 5.70 GBP to 6.20 GBP, while its 52-week range spans from 4.30 GBP to 11.00 GBP.
What Is Hvivo (HVO) Price Target According to Analysts?
The average 12-month price target for Hvivo is 15.50 GBP, with a high estimate of 25 GBP and a low estimate of 10 GBP. 5 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Buy. The stock has an +162.71% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.